Translational Development Acquisition Corp.’s (NASDAQ:TDACU) Quiet Period To End on February 3rd

Translational Development Acquisition’s (NASDAQ:TDACU) quiet period is set to end on Monday, February 3rd. Translational Development Acquisition had issued 15,000,000 shares in its public offering on December 23rd. The total size of the offering was $150,000,000 based on an initial share price of $10.00. During Translational Development Acquisition’s quiet period, insiders and underwriters involved in the IPO are prevented from issuing any research reports for the company because of SEC regulations. Following the end of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Translational Development Acquisition Price Performance

Shares of NASDAQ TDACU opened at $10.05 on Friday. Translational Development Acquisition has a 52-week low of $10.00 and a 52-week high of $10.05.

Hedge Funds Weigh In On Translational Development Acquisition

A hedge fund recently bought a new stake in Translational Development Acquisition stock. Calamos Advisors LLC purchased a new position in Translational Development Acquisition Corp. (NASDAQ:TDACU) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 375,000 shares of the company’s stock, valued at approximately $6,915,000.

Translational Development Acquisition Company Profile

Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.